Anakinra, COVID-19, Cytokine Storm

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
Covid19Cytokine StormMechanical Ventilation Complication
Interventions
DRUG

Anakinra

100 mg of Anakinra will be mixed with 100 mL of 0.9% saline solution for IV administration.

DRUG

0.9% Saline

The placebo preparation will consist of a 100 mL of 0.9% saline solution without the addition of anakinra.

Trial Locations (1)

10021

Weill Cornell Medcine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swedish Orphan Biovitrum

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER